Comparison of Recovery Characteristics between Fentanyl-Propofol & Dexmedetomidine: Propofol based Anaesthesia in Supratentorial Brain Tumor Surgery
DOI:
https://doi.org/10.37506/zm79p515Keywords:
Dexmedetomidine, fentanyl, propofol, recovery characteristics, supratentorial brain tumor.Abstract
Background: The aim of the present study is to compare the recovery profiles, perioperative hemodynamic changes and undesirable side-effects such as postoperative nausea and vomiting (PONV) and shivering of patients undergoing anaesthesia with fentanyl-propofol or dexmedetomidine–propofol in supratentorial brain tumour surgery.
Materials and Methods: In a prospective randomized double-blind study 70 ASA I-II patients aged 18-65 yrs
of either sex, scheduled for supratentorial craniotomy with a maximum anticipated duration of 300 minutes,
was allocated into two equal groups. One group received dexmedetomidine-propofol and other group received fentanyl-propofol as induction and maintenance of anaesthesia along with other drugs. Both the groups (n=35) received either i.v. dexmedetomidine or i.v. fentanyl 1 μg/kg 15mins prior to induction as loading dose followed by 0.5 μg/kg/ hr by continuous i.v. infusion peroperatively. At the end of surgery, recovery characteristics were assessed and recorded.
Results: Patients in Group 1 recovered early compared to Group 2 in terms of response to verbal command
(6.99±0.77 vs 8.79±0.88), extubation time (9.14±0.91 vs 10.83±1.06) and orientation time (11.14±0.703 vs12.76±1.10) which were found to be statistically significant. Induction dose of propofol and infusion dose of atracurium were significantly less in dexmedetomidine group in comparison to fentanyl group. Though in both the groups adverse effects were seen, but it was very less (less than 9%).
Conclusion: Propofol-fentanyl and propofol-dexmedetomidine are both suitable for elective supratentorial
craniotomy and provide similar intraoperative hemodynamic responses. Propofol-dexmedetomidine allows
earlier cognitive recovery.
References
Tanskanen PE, Kytta JV, Randell TT, Aantaa RE.
Dexmedetomidine asan anaesthetic adjuvant in
patients undergoing intracranial tumor surgery:
a double-blind, randomized and placebo-controlled
study. Br J Anaesth 2006; 97: 658-65.
Basali A, Mascha EJ, Kalfas I, Schubert A. Relation
between peri-operative hypertension and intracranial
haemorrhage after craniotomy. Anesthesiology 2000;
: 48-54.
Maze M, Tranquilli W. Alpha-2 adrenergic agonists:
defining the role in clinical anaesthesia. Anesthesiology
; 74: 581–605.
Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD.
The effects of increasing plasma concentrations of
dexmedetomidine in humans. Anesthesiology 2000;
: 382–94.
Guy J, Hindman BJ, Baker KZ, et al. Comparison of
remifentanil and fentanyl in patients undergoing
craniotomy for supratentorial space occupying lesions.
Anesthesiology 1997; 86: 514-24.
Turgut N, Turkmen A, Ali A, Altan A. Remifentanilpropofol
vs Dexmedetomidine-propofol- Anesthesia
for supratentorial Craniotomy. Middle East J
Anaesthesiol 2009;20(1):63-70.
He XY, Cao JP, Shi XY, Zhang H.dexmedetomidine
versus morphine or fentanyl in the management of
children after tonsillectomy and adenoidectomy: a
meta-analysis of randomized controlled trials. Ann
Otol Rhinol Laryngol. 2013 ;122(2):114-20.
Todd MM, Warner DS, Sokoll MD, et al. A prospective,
comparative trial of three anaesthetics for elective
supratentorial craniotomy. Propofol/fentanyl,
isoflurane/nitrous oxide, and fentanyl/nitrous oxide.
Anesthesiology1993; 78: 1005–20.
Keniya VM, Ladi S, Naphade R. Dexmedetomidine
attenuates sympathoadrenal response to tracheal
intubation and reduces perioperative anaesthetic
requirement. Indian J Anaesth 2011;55:352-7.
Ali AR, ElGhoneimyMN. Dexmedetomidine versus
fentanyl as adjuvant to propofol: comparative study
in children undergoing extracorporeal shock wave
lithotripsy. Eur J Anaesthesiol. 2010 Dec;27(12):1058-64
Ilhan O, Koruk S, Serin G, Erkutlu I, and Oner U.
Dexmedetomidine in the Supratentorial Craniotomy.
Eurasian J Med. 2010 Aug; 42(2): 61–65.
Feld JM, Hoffman WE, Stechert MM, Hoffman IW,
AnandaRC.Fentanyl or dexmedetomidine combined
with desflurane for bariatric surgery. J Clin Anesth;
, 18:24-28.
Sakaguchi Y, Takahashi S. Dexmedetomidine. Masui;
, 55:856-863.
Bekker A, Sturaitis MK. Dexmedetomidine for
neurological surgery. Neurosurgery 2005;57:1–10.
ARD JL JR, Bekker AY, Doyle WK. Dexmedetomidine
in awake craniotomy: a technical note. Surg Neurol
; 63:114-116.
Mack PF, Perrine K, Kobylarz E, Schwartz TH, Lien
CA. Dexmedetomidine and neurocognitive testing
in awake craniotomy. J Neurosurg Anesthesiol 2004;
:20-25.
Cortinez LI, Hsu YW, Sum-Ping ST, Young C, Keifer
JC, Macleod D, Robertson KM, Wright Dr, Moretti
EW, Somma J: Dexmedetomidine pharmacodynamics:
Part II: Crossover comparison of the analgesic effect
of dexmedetomidine and remifentanil in healthy
volunteers. Anesthesiology 2004; 101:1077-1083.
Cormack JR, Orme RM, Costello TG: The role of
alpha2-agonistsin neurosurgery. J Clin Neurosci 2005;
:375-378.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.